Breast Cancer
Showing NaN - NaN of 221
Breast Cancer Trial in United States (carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, vorinostat)
Breast Cancer Trial in Worldwide (palliative surgery, therapeutic conventional surgery, palliative radiation therapy)
Completed
- Breast Cancer
- Stage IV Breast Cancer
- palliative surgery
- +3 more
-
Mobile, Alabama
- +376 more
Jan 6, 2023
Breast Cancer Trial in United States (HKI-272, Surgical Resection, Capecitabine)
Active, not recruiting
- Breast Cancer
- HKI-272
- +3 more
-
San Francisco, California
- +17 more
Jan 30, 2023
Breast Cancer Trial in United States (Positron emission tomography (PET), Trastuzumab, Pertuzumab)
Active, not recruiting
- Breast Cancer
- Positron emission tomography (PET)
- +2 more
-
Birmingham, Alabama
- +9 more
Jan 20, 2023
Blood Vessel Function in Postmenopausal Women With Breast Cancer
Active, not recruiting
- Breast Cancer
- anastrozole
- +3 more
-
Rochester, MinnesotaMayo Clinic
Jan 17, 2023
Nonlinear Elasticity Mapping of Breast Masses
Recruiting
- Breast Cancer
- Ultrasound
-
Rochester, MinnesotaMayo Clinic
Jan 6, 2023
Prostate, Lung, Melanoma and Breast Cancer Patients Following
Recruiting
- Prostate Cancer
- +3 more
- SBRT
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Breast Cancer Trial in Greece, Israel, United States (MammaPrint, BluePrint, and Full-Genome Testing)
Recruiting
- Breast Cancer
- MammaPrint, BluePrint, and Full-Genome Testing
-
Birmingham, Alabama
- +117 more
Dec 1, 2022
Breast Cancer Trial in Worldwide (Olaparib, Placebo)
Breast Cancer Trial in United States (Photon, Proton)
Recruiting
- Breast Cancer
- Photon
- Proton
-
Birmingham, Alabama
- +40 more
Nov 18, 2022
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Breast Cancer Trial in Worldwide (exemestane, tamoxifen, triptorelin)
Breast Cancer Trial in Scottsdale, Rochester (Hypofractionation)
Active, not recruiting
- Breast Cancer
- Hypofractionation
-
Scottsdale, Arizona
- +1 more
Nov 11, 2022
Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)
Recruiting
- Stage I Breast Cancer
- +7 more
-
Baltimore, Maryland
- +6 more
Nov 11, 2022
Validation for Early Cancer Detection and Minimal Residual
Recruiting
- Brain Cancer
- +19 more
-
Duarte, California
- +6 more
Nov 10, 2022
Circulating Tumor DNA and Immunophenotyping as Potential
Recruiting
- Breast Cancer
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 7, 2022
Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal
Recruiting
- Breast Cancer
- +15 more
- ATRC-101
- +2 more
-
Phoenix, Arizona
- +10 more
Sep 28, 2022
Breast Cancer, Cardiac Toxicity Trial in Rochester (biological, drug, genetic, other, procedure)
Completed
- Breast Cancer
- Cardiac Toxicity
- trastuzumab
- +11 more
-
Rochester, MinnesotaMayo Clinic Cancer Research Consortium
Jul 12, 2022
Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining
Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)
Histology of Functional Density in Postmenopausal Breast
Completed
- Dense Breasts
- Breast Cancer
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 25, 2022